(Q33933508)

30 July 2017

Immunoliposomes for the targeted delivery of antitumor drugs (English)

1 reference

30 July 2017

Mastrobattista E

1

1 reference

30 July 2017

Koning GA

series ordinal

2

1 reference

30 July 2017

Storm G

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

Advanced Drug Delivery Reviews

30 July 2017

1 reference

30 July 2017

40

1 reference

30 July 2017

103-127

1 reference

30 July 2017

1-2

1 reference

Liposomes as carriers of cancer chemotherapy. Current status and future prospects

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Novel applications of liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Enhanced anticancer therapy mediated by specialized liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Clearance properties of liposomes involving conjugated proteins for targeting

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Ligand-targeted liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Antibody-directed liposomes: the development of a cell-specific cytotoxic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Efficient gene transfer to EGF receptor overexpressing cancer cells by means of EGF-labeled cationic liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Preparation of EGF labeled liposomes and their uptake by hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

The covalent coupling of Arg-Gly-Asp-containing peptides to liposomes: purification and biochemical function of the lipopeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Liposomal Arg-Gly-Asp analogs effectively inhibit metastatic B16 melanoma colonization in murine lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Liposome-anchored vascular endothelial growth factor aptamers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Preservation of antimyosin antibody activity after covalent coupling to liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Immunospecific targeting of liposomes to cells: a novel and efficient method for covalent attachment of Fab' fragments via disulfide bonds

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

The effect of blood serum on the size and stability of phospholipid liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Effects of temperature and lipid composition on the serum albumin-induced aggregation and fusion of small unilamellar vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Influence of liposome charge and composition on their interaction with human blood serum proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Complement activation in human serum by liposome-encapsulated hemoglobin: the role of natural anti-phospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Uptake and processing of immunoglobulin-coated liposomes by subpopulations of rat liver macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Influence of liposome charge on the association of liposomes with Kupffer cells in vitro. Effects of divalent cations and competition with latex particles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Immune clearance of liposomes inhibited by an anti-Fc receptor antibody in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Role of Fc gamma receptors in cancer and infectious disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Fc-receptor-mediated targeting of antibody-bearing liposomes containing dideoxycytidine triphosphate to human monocyte/macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Polymer-coated long-circulating microparticulate pharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Immunoliposomes bearing polyethyleneglycol-coupled Fab' fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Immunogenicity of immunoliposomes: reactivity against species-specific IgG and liposomal phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Simultaneous measurement of liposome extravasation and content release in tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Delivery of molecular and cellular medicine to solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Anti-HER2 immunoliposomes for targeted therapy of human tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

The pharmacology of monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Immunoliposome-mediated targeting of anti-cancer drugs in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Poly(ethylene glycol)--lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Preparation of long-circulating immunoliposomes containing adriamycin by a novel method to coat immunoliposomes with poly(ethylene glycol).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Proteins and peptides bound to long-circulating liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Poly(ethylene glycol)-coated anti-cardiac myosin immunoliposomes: factors influencing targeted accumulation in the infarcted myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Modulation of doxorubicin resistance in multidrug-resistant cells by liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Reversal of multidrug resistance in HL-60 cells by verapamil and liposome-encapsulated doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Modulation of multidrug resistance in Chinese hamster cells by liposome-encapsulated doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Liposomes with detachable polymer coating: destabilization and fusion of dioleoylphosphatidylethanolamine vesicles triggered by cleavage of surface-grafted poly(ethylene glycol).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Stable target-sensitive immunoliposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Temperature- and pH-sensitive liposomes for drug targeting

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Enhanced delivery to target cells by heat-sensitive immunoliposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

pH-sensitive immunoliposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Use of photosensitive, antibody directed liposomes to destroy target populations of cells in bone marrow: a potential purging method for autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Study of the mechanisms of laser-induced release of liposome-encapsulated dye.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Lipophilic 1-beta-D-arabinofuranosyl cytosine derivatives in liposomal formulations for oral and parenteral antileukemic therapy in the murine L1210 leukemia model

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

5'-O-Palmitoyl- and 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine--novel lipophilic analogues of 5'-fluoro-2'-deoxyuridine: synthesis, incorporation into liposomes and preliminary biological results

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

In-vitro stability and cytostatic activity of liposomal formulations of 5-fluoro-2'-deoxyuridine and its diacylated derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Circumvention of the methotrexate transport system by methotrexate-phosphatidylethanolamine derivatives: effect of fatty acid chain length

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Characterization of organ-specific immunoliposomes for delivery of 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine in a mouse lung-metastasis model

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Antitumoral activity of liposomes and immunoliposomes containing 5-fluorouridine prodrugs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Antiproliferative effect of immunoliposomes containing 5-fluorodeoxyuridine-dipalmitate on colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

In vivo distribution and antitumour activity of liposomal 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine from immunoliposomes to colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

The effects of pH and intraliposomal buffer strength on the rate of liposome content release and intracellular drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Endocytosis of liposomes and intracellular fate of encapsulated molecules: encounter with a low pH compartment after internalization in coated vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Sterically stabilized pH-sensitive liposomes. Intracellular delivery of aqueous contents and prolonged circulation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

pH-sensitive liposomes: acid-induced liposome fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

pH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Cytoplasmic delivery of calcein mediated by liposomes modified with a pH-sensitive poly(ethylene glycol) derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Application of membrane-active peptides for drug and gene delivery across cellular membranes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

pH-dependent bilayer destabilization by an amphipathic peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Design of a short membrane-destabilizing peptide covalently bound to liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Membrane anchorage brings about fusogenic properties in a short synthetic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Membrane fusion induced by 11-mer anionic and cationic peptides: a structure-function study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma model

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Immunospecific targeting of immunoliposomes, F(ab')2 and IgG to red blood cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Immunospecific targeting of liposomes to erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Development of anti-p185HER2 immunoliposomes for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

The clinical significance of HAMA in patients treated with mouse monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

1 reference

7 January 2021

Human antibodies from transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Production of fully human antibodies by transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Functional immunoliposomes harboring a biosynthetically lipid-tagged single-chain antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Biosynthetically lipid-modified human scFv fragments from phage display libraries as targeting molecules for immunoliposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

All you wanted to know about SELEX.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

From oligonucleotide shapes to genomic SELEX: novel biological regulatory loops

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Designing of thermosensitive liposomes from natural lipids for multimodality cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Thermosensitive liposomal taxol formulation: heat-mediated targeted drug delivery in murine melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Biodistribution of pH-sensitive immunoliposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Comparison of lipid vesicle fusion induced by the putative fusion peptide of fertilin (a protein active in sperm-egg fusion) and the NH2-terminal domain of the HIV2 gp41

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

pH-induced destabilization of lipid bilayers by a lipopeptide derived from influenza hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Antibody-mediated targeting of liposomes to red cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

A new application for liposomes in cancer therapy. Immunoliposomes bearing enzymes (immuno-enzymosomes) for site-specific activation of prodrugs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

A monoclonal antibody-beta-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Immunoliposomes as enzyme-carriers (immuno-enzymosomes) for antibody-directed enzyme prodrug therapy (ADEPT): optimization of prodrug activating capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Triggerable liposomal fusion by enzyme cleavage of a novel peptide-lipid conjugate

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Rocking the foundations of solid tumor growth by attacking the tumor's blood supply

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Selectins as new targets for immunoliposome-mediated drug delivery. A potential way of anti-inflammatory therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Adhesion molecules: a new target for immunoliposome-mediated drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Cellular uptake of liposomes targeted to intercellular adhesion molecule-1 (ICAM-1) on bronchial epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

Vascular targeting as a strategy for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900043-5

7 January 2021

10.1016/S0169-409X(99)00043-5

Identifiers

DOI

1 reference

30 July 2017

1 reference